Dr. Adam Cohen received his medical degree and did his internal medicine residency at the University of Pennsylvania, Philadelphia. He completed a hematology/oncology fellowship at Memorial Sloan-Kettering Cancer Center, New York. Currently, he is Director of Myeloma Immunotherapy, and an Associate Professor of Medicine at the Abramson Cancer Center, University of Pennsylvania, Philadelphia.

Dr. Cohen is board certified in medical oncology and hematology and treats patients with myeloma, AL amyloidosis and related plasma cell disorders. He is a member of ASCO, ASH, and the International Myeloma Society. His research interests involve novel therapeutics for plasma cell diseases, particularly vaccines, antibodies and cellular immunotherapies.